Company intelligence / Profile preview
Omnitura Therapeutics
Henderson, Nevada, United Statesomnituratherapeutics.com ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Phase 1
01
Overview
Omnitura Therapeutics is a clinical-stage biopharmaceutical company focused on commercializing Aneustat™, described as the world’s first multivalent immuno-oncology drug candidate. The lead program targets prostate cancer, with Aneustat™ having completed Phase I/IIa trials and now entering Phase II. The therapy aims to kill cancer cells at all stages via apoptosis without developing resistance, can be combined with standard-of-care agents, and leverages plant-derived compounds. The company positions its approach as a systems biology solution addressing both cancer complexity and comorbid chronic diseases.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeMultivalent immuno-oncology therapyPlant-derived therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Omnitura Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Omnitura Therapeutics.